PSG logo

PharmaSGP Holding SE Stock Price

HMSE:PSG Community·€363.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PSG Share Price Performance

€31.60
2.80 (9.72%)
€31.60
2.80 (9.72%)
Price €31.60

PSG Community Narratives

There are no narratives available yet.

Recent PSG News & Updates

PharmaSGP Holding SE Key Details

€126.4m

Revenue

€12.1m

Cost of Revenue

€114.4m

Gross Profit

€95.4m

Other Expenses

€18.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
1.64
Gross Margin
90.45%
Net Profit Margin
14.96%
Debt/Equity Ratio
156.9%

PharmaSGP Holding SE Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Good value with adequate balance sheet.

1 Risk
2 Rewards

About PSG

Founded
2012
Employees
98
CEO
Peter Gerckens
WebsiteView website
pharmasgp.com

PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company’s pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Revitensin, a drug for the treatment of hair loss; Dorisol for neuralgia (nerve pain), headaches, and migraines; Fulminan, a beauty drink; Lindaven, a pharmaceutical drops to treat their unpleasant problem; and SCLEROCALMAN, a drug for the treatment of clogged cerebral blood vessels. It also offers Prostacalman, a medication for cystitis and urination discomfort in a benign enlarged prostate; Revoten for women with weak connective tissue; Mindalin, a micronutrient drink for a healthy cardiovascular system; MELISTON, a prescription-free tablets to treat anxiety, restlessness, and mood swings; Deruba, a cream for skin redness; Lentisol that prevents the formation of new pigment spots; Neodolor, a headache tablet; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. The company sells its products through pharmacies and wholesalers. It also exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

German Market Performance

  • 7 Days: 2.7%
  • 3 Months: 0.3%
  • 1 Year: 14.6%
  • Year to Date: 13.3%
The market has climbed by 2.7% over the past week, with every sector up and the Industrials sector leading the way. As for the past 12 months, the market is up 15%. Earnings are forecast to grow by 17% annually. Market details ›